Original Article
Development and validation of a glioma prognostic model based on telomere-related genes and immune infiltration analysis
Translational Cancer Research
2024;
13
(7)
:3182-3199
.
(31 July 2024)
Systematic analysis of TREM2 and its carcinogenesis in pancreatic cancer
Translational Cancer Research
2024;
13
(7)
:3200-3216
.
(31 July 2024)
Machine learning-based integration of CD8 T cell-related gene signatures for comprehensive prognostic assessment in lung adenocarcinoma
Translational Cancer Research
2024;
13
(7)
:3217-3241
.
(31 July 2024)
Prognostic factors and treatment strategies of limited-stage primary esophageal small-cell carcinoma—a SEER database analysis
Translational Cancer Research
2024;
13
(7)
:3242-3250
.
(31 July 2024)
Effect and mechanism of curcumin on colon cancer cell senescence through early growth response 1 (EGR1)
Translational Cancer Research
2024;
13
(7)
:3251-3261
.
(31 July 2024)
LncRNA CBR3-AS1 is associated with the BCR::ABL1 kinase independent mechanism of tyrosine kinase inhibitor (TKI) resistance in chronic myeloid leukemia patients
Translational Cancer Research
2024;
13
(7)
:3262-3272
.
(31 July 2024)
Tumor hypoxia in immune infiltration and prognosis of bladder cancer
Translational Cancer Research
2024;
13
(7)
:3273-3284
.
(31 July 2024)
A novel m6A/m5C/m1A/m7G‐related classification and risk signature predicts prognosis and reveals immunotherapy inclination in gastric cancer
Translational Cancer Research
2024;
13
(7)
:3285-3298
.
(31 July 2024)
Pan-cancer bioinformatics analysis of hepatic leukemia factor and further validation in colorectal cancer
Translational Cancer Research
2024;
13
(7)
:3299-3317
.
(31 July 2024)
Treatments and prognostic outcomes of combined hepatocellular-cholangiocarcinoma with distant metastasis: an analysis based on SEER data
Translational Cancer Research
2024;
13
(7)
:3318-3327
.
(31 July 2024)
Correlation between initial alkaline phosphatase levels and overall survival in newly diagnosed multiple myeloma patients
Translational Cancer Research
2024;
13
(7)
:3328-3337
.
(31 July 2024)
Novel mitochondrial-related gene signature predicts prognosis and immunological status in glioma
Translational Cancer Research
2024;
13
(7)
:3338-3353
.
(31 July 2024)
Comprehensive analysis to identify the relationship between CALD1 and immune infiltration in glioma
Translational Cancer Research
2024;
13
(7)
:3354-3369
.
(31 July 2024)
Comparison of Cox regression and generalized Cox regression models to machine learning in predicting survival of children with diffuse large B-cell lymphoma
Translational Cancer Research
2024;
13
(7)
:3370-3381
.
(31 July 2024)
Identification and validation of ferroptosis-related prognostic gene signature in patients with cervical cancer
Translational Cancer Research
2024;
13
(7)
:3382-3396
.
(31 July 2024)
MiR-1271-5p promotes the growth and migration of neuroblastoma cells by regulating ACY-1
Translational Cancer Research
2024;
13
(7)
:3397-3406
.
(31 July 2024)
SCG2 and CPE may be novel markers for the identification of pancreatic neuroendocrine tumors and solid pseudopapillary neoplasms
Translational Cancer Research
2024;
13
(7)
:3407-3417
.
(31 July 2024)
Identification of a cancer driver gene-associated lncRNA signature for prognostic prediction and immune response evaluation in clear cell renal cell carcinoma
Translational Cancer Research
2024;
13
(7)
:3418-3436
.
(31 July 2024)
Short-term outcomes of three- and two-field lymphadenectomy with minimally invasive esophagectomy for esophageal cancer: a propensity score-matching analysis
Translational Cancer Research
2024;
13
(7)
:3437-3445
.
(31 July 2024)
SLC12A8 upregulation promotes colorectal cancer progression and chemoresistance
Translational Cancer Research
2024;
13
(7)
:3446-3464
.
(31 July 2024)
The roles of lncRNA AP001469.3 in clinical implications, immune landscape and carcinogenesis of colorectal cancer
Translational Cancer Research
2024;
13
(7)
:3465-3481
.
(31 July 2024)
Survival and analysis of prognostic factors for fibroblastic osteosarcoma patients: a population-based study
Translational Cancer Research
2024;
13
(7)
:3482-3494
.
(31 July 2024)
Telomere-related gene risk model for prognosis prediction in colorectal cancer
Translational Cancer Research
2024;
13
(7)
:3495-3521
.
(31 July 2024)
The ratio of PKM1/PKM2 is the key factor affecting the glucose metabolism and biological function of colorectal cancer cells
Translational Cancer Research
2024;
13
(7)
:3522-3535
.
(31 July 2024)
SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma
Translational Cancer Research
2024;
13
(7)
:3536-3555
.
(31 July 2024)
Stratifying osteosarcoma patients using an epigenetic modification-related prognostic signature: implications for immunotherapy and chemotherapy selection
Translational Cancer Research
2024;
13
(7)
:3556-3574
.
(31 July 2024)
Characteristics, clinical significance, and cancer immune interactions of lipid metabolism in prostate cancer
Translational Cancer Research
2024;
13
(7)
:3575-3588
.
(31 July 2024)
Monocytes-to-lymphocytes ratio increases the prognostic value of circulating tumor cells in non-small cell lung cancer: a prospective study
Translational Cancer Research
2024;
13
(7)
:3589-3598
.
(31 July 2024)
Bioinformatics reveals the potential mechanisms and biomarkers of necroptosis in neuroblastoma
Translational Cancer Research
2024;
13
(7)
:3599-3619
.
(31 July 2024)
Dendritic cell-related hub genes in head-and-neck squamous cell carcinoma: implications for prognosis and immunotherapy
Translational Cancer Research
2024;
13
(7)
:3620-3636
.
(31 July 2024)
Clinical characteristics and prognosis of liver metastases with unknown primary site
Translational Cancer Research
2024;
13
(7)
:3637-3651
.
(31 July 2024)
Eleven inflammation-related genes risk signature model predicts prognosis of patients with breast cancer
Translational Cancer Research
2024;
13
(7)
:3652-3667
.
(31 July 2024)
Expression profiles of serum transfer RNA-derived fragments and their potential roles in non-small cell lung cancer
Translational Cancer Research
2024;
13
(7)
:3668-3677
.
(31 July 2024)
Identification of a ferroptosis-related gene signature for the prognosis of pediatric neuroblastoma
Translational Cancer Research
2024;
13
(7)
:3678-3694
.
(31 July 2024)
CDK4/6 inhibition to resensitize BRAF/EGFR inhibitor in patient-derived BRAF/PTEN-mutant colon cancer cells
Translational Cancer Research
2024;
13
(7)
:3695-3703
.
(31 July 2024)
Development of a novel colon adenocarcinoma m6A-related lncRNA pair prognostic model
Translational Cancer Research
2024;
13
(7)
:3704-3717
.
(31 July 2024)
A retrospective study of anlotinib in patients with persistent, recurrent or metastatic cervical and endometrial cancer
Translational Cancer Research
2024;
13
(7)
:3718-3728
.
(31 July 2024)
TLK2 promotes progression of hepatocellular carcinoma through Wnt/β-catenin signaling
Translational Cancer Research
2024;
13
(7)
:3729-3741
.
(31 July 2024)
Identification of a novel cellular senescence-related lncRNA signature for prognosis and immune response in osteosarcoma
Translational Cancer Research
2024;
13
(7)
:3742-3759
.
(31 July 2024)
Identification and validation of endoplasmic reticulum stress-related genes that enhance immunotherapy in colon cancer
Translational Cancer Research
2024;
13
(7)
:3760-3770
.
(31 July 2024)
Identification of hub genes and key modules in laryngeal squamous cell carcinoma
Translational Cancer Research
2024;
13
(7)
:3771-3782
.
(31 July 2024)
Comparative efficacy and safety of first-line tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and network meta-analysis
Translational Cancer Research
2024;
13
(7)
:3783-3797
.
(31 July 2024)
Integrating network pharmacology and computational biology to propose Yiqi Sanjie formula’s mechanisms in treating NSCLC: molecular docking, ADMET, and molecular dynamics simulation
Translational Cancer Research
2024;
13
(7)
:3798-3813
.
(31 July 2024)
Exploring the effects of matrix metalloproteinase-13 on the malignant biological behavior of tongue squamous cell carcinoma via the TNF signaling pathway based on bioinformatics methods
Translational Cancer Research
2024;
13
(7)
:3814-3825
.
(31 July 2024)
Identifying key pathogenic mechanisms and potential intervention targets for recurrence after laryngeal cancer treatment through bioinformatics screening
Translational Cancer Research
2024;
13
(7)
:3826-3841
.
(31 July 2024)
The mechanism of Taohong Siwu decoction in treating chemotherapy-induced peripheral neuropathy: a network pharmacology and molecular docking study
Translational Cancer Research
2024;
13
(7)
:3842-3853
.
(31 July 2024)
Review Article
The role of dysregulated metabolism and associated genes in gastric cancer initiation and development
Translational Cancer Research
2024;
13
(7)
:3854-3868
.
(31 July 2024)
Research progress on factors affecting the sensitivity of breast cancer to radiotherapy: a narrative review
Translational Cancer Research
2024;
13
(7)
:3869-3888
.
(31 July 2024)
Combination approach using neoadjuvant therapy with radical prostatectomy for improving oncological outcomes of high-risk prostate cancer: a narrative review
Translational Cancer Research
2024;
13
(7)
:3889-3897
.
(31 July 2024)
The role of immune metabolism in skin cancers: implications for pathogenesis and therapy
Translational Cancer Research
2024;
13
(7)
:3898-3903
.
(31 July 2024)
Clinical research progress of telomerase targeted cancer immunotherapy: a literature review
Translational Cancer Research
2024;
13
(7)
:3904-3921
.
(31 July 2024)
Case Report
Brain stem angioleiomyoma mimicking meningioma: a case report
Translational Cancer Research
2024;
13
(7)
:3922-3927
.
(31 July 2024)
Retraction
Retraction: involvement of DNA methyltransferase 1 (DNMT1) and multidrug resistance-associated proteins in 2-methoxyestradiol-induced cytotoxicity in EC109/Taxol cells
Translational Cancer Research
2024;
13
(7)
:3928
.
(31 July 2024)
